Malignant Glioma Therapeutics Market Overview The Malignant Glioma Therapeutics Market is growing steadily as a result of advancements in biotechnology, targeted therapy development, and an increasing prevalence of glioblastomas and other aggressive brain tumors. Malignant gliomas, such as glioblastoma multiforme (GBM), are the most common and aggressive type of primary brain cancer,...